184 related articles for article (PubMed ID: 35013433)
1. Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.
Masilela C; Adeniyi OV; Benjeddou M
Sci Rep; 2022 Jan; 12(1):337. PubMed ID: 35013433
[TBL] [Abstract][Full Text] [Related]
2. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study.
Peer N; Steyn K; Lombard C; Gaziano T; Levitt N
Eur J Prev Cardiol; 2014 Dec; 21(12):1549-56. PubMed ID: 23881149
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS).
Raal FJ; Blom DJ; Naidoo S; Bramlage P; Brudi P
Cardiovasc J Afr; 2013 Sep; 24(8):330-8. PubMed ID: 24240385
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.
Asiki G; Murphy GA; Baisley K; Nsubuga RN; Karabarinde A; Newton R; Seeley J; Young EH; Kamali A; Sandhu MS
PLoS One; 2015; 10(5):e0126166. PubMed ID: 25974077
[TBL] [Abstract][Full Text] [Related]
6. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
Pitso L; Mofokeng TRP; Nel R
BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa.
Omodanisi EI; Tomose Y; Okeleye BI; Ntwampe SKO; Aboua YG
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255455
[TBL] [Abstract][Full Text] [Related]
10. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.
Weeda ER; Bishu KG; Ward R; Axon RN; Taber DJ; Gebregziabher M
BMC Cardiovasc Disord; 2020 Oct; 20(1):449. PubMed ID: 33059602
[TBL] [Abstract][Full Text] [Related]
11. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.
Anto EO; Obirikorang C; Annani-Akollor ME; Adua E; Donkor S; Acheampong E; Asamoah EA
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330902
[No Abstract] [Full Text] [Related]
13. Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women.
Ellman N; Keswell D; Collins M; Tootla M; Goedecke JH
Atherosclerosis; 2015 Jun; 240(2):311-7. PubMed ID: 25864161
[TBL] [Abstract][Full Text] [Related]
14. National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.
Pengpid S; Peltzer K
Sci Rep; 2022 Jun; 12(1):10478. PubMed ID: 35729323
[TBL] [Abstract][Full Text] [Related]
15. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, patterns and associated risk factors for dyslipidaemia among individuals attending the diabetes clinic at a tertiary hospital in Central Malawi.
Filisa-Kaphamtengo F; Ngoma J; Mukhula V; Matemvu Z; Kapute D; Banda P; Phiri T; Mipando M; Hosseinipour MC; Katundu KGH
BMC Cardiovasc Disord; 2023 Nov; 23(1):548. PubMed ID: 37946116
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China.
Chen Y; Du J; Zhou N; Song Y; Wang W; Hong X
BMJ Open; 2023 Dec; 13(12):e075860. PubMed ID: 38128931
[TBL] [Abstract][Full Text] [Related]
18. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.
Ting RZ; Yang X; Yu LW; Luk AO; Kong AP; Tong PC; So WY; Chan JC; Ma RC
Cardiovasc Diabetol; 2010 Nov; 9():77. PubMed ID: 21092182
[TBL] [Abstract][Full Text] [Related]
19. Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication.
Maahs DM; Ogden LG; Dabelea D; Snell-Bergeon JK; Daniels SR; Hamman RF; Rewers M
Diabetologia; 2010 Dec; 53(12):2518-25. PubMed ID: 20820753
[TBL] [Abstract][Full Text] [Related]
20. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
